Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 356501 - 356520 out of 566103 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Lithuania | (L01FA01) rituximab | Rixathon 100 mg koncentratas infuziniam tirpalui 10 ml N2 (Sandoz GmbH, Austrija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Leukemia, Lymphocytic, Chronic, B-Cell;Wegener Granulomatosis;Microscopic Polyangiitis;Pemphigus | SandozGmbH,Austrija |
| Lithuania | (L01FA01) rituximab | Ruxience 100 mg koncentratas infuziniam tirpalui 10 ml N1 (Pfizer Europe MA EEIG, Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Arthritis, Rheumatoid;Microscopic Polyangiitis;Pemphigus | PfizerEuropeMAEEIG,Belgija |
| Lithuania | (L01FA01) rituximab | Rixathon 500 mg koncentratas infuziniam tirpalui 50 ml N1 (Sandoz GmbH, Austrija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Leukemia, Lymphocytic, Chronic, B-Cell;Wegener Granulomatosis;Microscopic Polyangiitis;Pemphigus | SandozGmbH,Austrija |
| Lithuania | (L01FA01) rituximab | Ruxience 500 mg koncentratas infuziniam tirpalui 50 ml N1 (Pfizer Europe MA EEIG, Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Arthritis, Rheumatoid;Microscopic Polyangiitis;Pemphigus | PfizerEuropeMAEEIG,Belgija |
| Lithuania | (L01FB01) inotuzumab ozogamicin | BESPONSA 1 mg milteliai infuzinio tirpalo koncentratui N1 (Pfizer Europe MA EEIG, Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | PfizerEuropeMAEEIG,Belgija |
| Lithuania | (L01FC01) daratumumab | DARZALEX 20 mg/ml koncentratas infuziniam tirpalui 20 ml N1 (Janssen-Cilag International N.V., Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania | (L01FC01) daratumumab | DARZALEX 20 mg/ml koncentratas infuziniam tirpalui 5 ml N1 (Janssen-Cilag International N.V., Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania | (L01FC01) daratumumab | DARZALEX 1800 mg injekcinis tirpalas 15 ml N1 (Janssen-Cilag International N.V., Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania | (L01FD01) trastuzumab | Ogivri 150 mg milteliai infuzinio tirpalo koncentratui N1 (Biosimilar Collaborations Ireland Limited, Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BiosimilarCollaborationsIrelandLimited,Airija |
| Lithuania | (L01FD01) trastuzumab | Ontruzant 150 mg milteliai infuzinio tirpalo koncentratui N1 (Samsung Bioepis NL B.V., Nyderlandai) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | SamsungBioepisNLB.V.,Nyderlandai |
| Lithuania | (L01FD01) trastuzumab | Trazimera 150 mg milteliai infuzinio tirpalo koncentratui N1 (Pfizer Europe MA EEIG, Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PfizerEuropeMAEEIG,Belgija |
| Lithuania | (L01FD01) trastuzumab | Zercepac 150 mg milteliai infuzinio tirpalo koncentratui N1 (Accord Healthcare S.L.U., Ispanija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | AccordHealthcareS.L.U.,Ispanija |
| Lithuania | (L01FD01) trastuzumab | Zercepac 420 mg milteliai infuzinio tirpalo koncentratui N1 (Accord Healthcare S.L.U., Ispanija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | AccordHealthcareS.L.U.,Ispanija |
| Lithuania | (L01FD01) trastuzumab | Zercepac 60 mg milteliai infuzinio tirpalo koncentratui N1 (Accord Healthcare S.L.U., Ispanija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | AccordHealthcareS.L.U.,Ispanija |
| Lithuania | (L01FD02) pertuzumab | Perjeta 420 mg/14 ml koncentratas infuziniam tirpalui 14 ml N1 (Roche Registration GmbH, Vokietija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH,Vokietija |
| Lithuania | (L01FD04) trastuzumab deruxtecan | Enhertu 100 mg milteliai infuzinio tirpalo koncentratui N1 (Daiichi Sankyo Europe GmbH, Vokietija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | DaiichiSankyoEuropeGmbH,Vokietija |
| Lithuania | (L01FE02) panitumumab | Vectibix 20 mg/ml koncentratas infuziniam tirpalui 5 ml N1 (Amgen Europe B.V., Nyderlandai) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenEuropeB.V.,Nyderlandai |
| Lithuania | (L01FF01) nivolumab | OPDIVO 10 mg/ml koncentratas infuziniam tirpalui 10 ml N1 (Bristol-Myers Squibb Pharma EEIG, Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Airija |
| Lithuania | (L01FF01) nivolumab | OPDIVO 10 mg/ml koncentratas infuziniam tirpalui 24 ml N1 (Bristol-Myers Squibb Pharma EEIG, Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Airija |
| Lithuania | (L01FF01) nivolumab | OPDIVO 10 mg/ml koncentratas infuziniam tirpalui 4 ml N1 (Bristol-Myers Squibb Pharma EEIG, Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Airija |
Pages
